| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Opiant Pharmaceuticals Inc (NASDAQ: OPNT)
OPNT Technical Analysis
3
| As on 2nd Mar 2023 OPNT SHARE Price closed @ 20.65 and we RECOMMEND Sell for LONG-TERM with Stoploss of 21.87 & Sell for SHORT-TERM with Stoploss of 24.80 we also expect STOCK to react on Following IMPORTANT LEVELS. |
OPNTSHARE Price
| Open | 20.65 | Change | Price | % |
| High | 20.65 | 1 Day | 0.00 | 0.00 |
| Low | 20.65 | 1 Week | -0.15 | -0.72 |
| Close | 20.65 | 1 Month | 0.27 | 1.32 |
| Volume | N/A | 1 Year | 1.20 | 6.17 |
| 52 Week High 36.79 | 52 Week Low 9.38 | ||||
NASDAQ USA Most Active Stocks
| TSLA | 244.40 | 4.06% |
| TTOO | 0.07 | -12.50% |
| SOFI | 8.18 | 0.74% |
| FFIE | 0.33 | 6.45% |
| PONO | 1.72 | 2.38% |
| AMD | 124.92 | 3.20% |
| IDEX | 0.06 | 0.00% |
| NKLA | 0.70 | 14.75% |
| AMZN | 123.43 | -0.66% |
| AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| OPNT Daily Charts |
OPNT Intraday Charts |
Whats New @ Bazaartrend |
OPNT Free Analysis |
|
|
OPNT Important Levels Intraday
| RESISTANCE | 20.65 |
| RESISTANCE | 20.65 |
| RESISTANCE | 20.65 |
| RESISTANCE | 20.65 |
| RESISTANCE | 20.65 |
| RESISTANCE | 20.65 |
| RESISTANCE | 20.65 |
| RESISTANCE | 20.65 |
OPNT Forecast April 2024
| 4th UP Forecast | 33.37 |
| 3rd UP Forecast | 29.29 |
| 2nd UP Forecast | 26.77 |
| 1st UP Forecast | 24.25 |
| 1st DOWN Forecast | 17.05 |
| 2nd DOWN Forecast | 14.53 |
| 3rd DOWN Forecast | 12.01 |
| 4th DOWN Forecast | 7.93 |
OPNT Weekly Forecast
| 4th UP Forecast | 30.07 |
| 3rd UP Forecast | 27.05 |
| 2nd UP Forecast | 25.18 |
| 1st UP Forecast | 23.32 |
| 1st DOWN Forecast | 17.98 |
| 2nd DOWN Forecast | 16.12 |
| 3rd DOWN Forecast | 14.25 |
| 4th DOWN Forecast | 11.23 |
OPNT Forecast2024
| 4th UP Forecast | 79.17 |
| 3rd UP Forecast | 60.4 |
| 2nd UP Forecast | 48.8 |
| 1st UP Forecast | 37.2 |
| 1st DOWN Forecast | 4.1 |
| 2nd DOWN Forecast | -7.5 |
| 3rd DOWN Forecast | -19.1 |
| 4th DOWN Forecast | -37.87 |
Opiant Pharmaceuticals Inc ( NASDAQ USA Symbol : OPNT )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
OPNT Business Profile
Opiant Pharmaceuticals, Inc., a specialty pharmaceutical company, develops medicines for addictions and drug overdose. The company offers NARCAN nasal spray, a treatment to reverse opioid overdoses. Its pipeline of product candidates includes medicines for the treatment for opioid overdose reversal; alcohol use disorders; acute cannabinoid overdose; and opioid use disorders. The company was formerly known as Lightlake Therapeutics Inc. and changed its name to Opiant Pharmaceuticals, Inc. in January 2016. Opiant Pharmaceuticals, Inc. was incorporated in 2005 and is headquartered in Santa Monica, California. Address: 233 Wilshirre Boulevard, Santa Monica, CA, United States, 90401
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service